SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001178879-19-000049
Filing Date
2019-05-29
Accepted
2019-05-29 06:32:55
Documents
20
Period of Report
2019-05-28
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K form8-kexpandedpenncollab.htm 8-K 32326
2 EXHIBIT 99.1 exhibit9919.htm EX-99.1 27336
3 EXHIBIT 99.2 exhibit992.htm EX-99.2 19674
4 amicuslogoa03.jpg GRAPHIC 127191
5 exhibit991image1a11.jpg GRAPHIC 127191
6 exhibit991image2.gif GRAPHIC 4431
7 exhibit992001.jpg GRAPHIC 109247
8 exhibit992002.jpg GRAPHIC 248532
9 exhibit992003.jpg GRAPHIC 169474
10 exhibit992004.jpg GRAPHIC 174958
11 exhibit992005.jpg GRAPHIC 133640
12 exhibit992006.jpg GRAPHIC 129570
13 exhibit992007.jpg GRAPHIC 128798
14 exhibit992008.jpg GRAPHIC 138679
15 exhibit992009.jpg GRAPHIC 114460
16 exhibit992010.jpg GRAPHIC 110027
17 exhibit992011.jpg GRAPHIC 148231
18 exhibit992012.jpg GRAPHIC 144089
19 exhibit992013.jpg GRAPHIC 195763
20 exhibit992014.jpg GRAPHIC 59779
  Complete submission text file 0001178879-19-000049.txt   3183601
Mailing Address 1 CEDAR BROOK DRIVE CRANBURY NJ 08512
Business Address 1 CEDAR BROOK DRIVE CRANBURY NJ 08512 (609) 662-2000
AMICUS THERAPEUTICS, INC. (Filer) CIK: 0001178879 (see all company filings)

IRS No.: 200422823 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33497 | Film No.: 19859636
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences